CUSIP 81728A108COMSNSEQ1 2025
17 filings · latest Mar 7, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 585.6K | $230.7K |
| 2 | Ikarian Capital, LLC | 450.0K | $177.3K |
| 3 | Catalio Capital Management, LP | 294.4K | $116.0K |
| 4 | Renaissance Technologies LLC | 177.3K | $69.9K |
| 5 | Geode Capital Management, LLC | 150.7K | $59.4K |
| 6 | Boothbay Fund Management, LLC | 108.7K | $42.8K |
| 7 | Ubs Group AG | 42.5K | $16.8K |
| 8 | Northern Trust Corp | 26.0K | $10.2K |
| 9 |
| 4 | Aug 4, 2023 | Cambrian Biopharma Inc | 13G/A | — | — | SEC |
| 5 | Jun 2, 2023 | Apeiron Investment Group Ltd. | 13D/A | — | — | SEC |
| 6 | May 23, 2023 | Apeiron Investment Group Ltd. | 13D/A | 3.1% | 955.7K | SEC |
| 7 | Mar 9, 2023 | Apeiron Investment Group Ltd. | 13D/A | 3.1% | 955.7K | SEC |
| 8 | Feb 14, 2023 | Cambrian Biopharma Inc | 13G/A | — | — | SEC |
| 9 | Feb 13, 2023 | Peyer James | 13G/A | — | — | SEC |
| 10 | Nov 21, 2022 | Apeiron Investment Group Ltd. | 13D/A | 3.1% | 955.7K | SEC |
See the full Schedule 13D/13G history for Sensei Biotherapeutics Inc.
Unlock full history| State Street Corp |
| 25.8K |
| $10.2K |
| 10 | Cresset Asset Management, LLC | 19.7K | $7.8K |